Single Molecule Counting Tech Firm Singulex Secures $55M in Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Singulex today announced it secured $55 million in debt and equity financing.

The company secured a $40 million debt facility from Oxford Finance and Silicon Valley Bank, and in June, it raised $15 million in equity financing. Singulex said it plans to use the financing to further develop its in vitro diagnostics business based on its Single Molecule Counting technology.

The Alameda, Calif.-based company raised $19 million in a financing round in January 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.